I'm curious as to why they did the R/S now, only because the last filing, if memory serves, gave them until May 30, 2017 to bring the price up. As the end of the trial approaches, and as top line would be closer to availability by that date in May, it might have increased to the $1 price. It certainly seemed they had time to wait. With no catalysts in immediate sight, why now?